These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 8719606)
1. Lipoprotein(a) plasma levels and apo(a) isoforms are not associated with longevity or disability in a sample of Italian octo-nonagenarians. Associazione Medica Sabin. Zuliani G; Bader G; Imbastaro T; Mezzetti A; Taddeo U; Kostner GM; Fellin R Aging (Milano); 1995 Oct; 7(5):385-91. PubMed ID: 8719606 [TBL] [Abstract][Full Text] [Related]
2. Apolipoprotein E polymorphism is not associated with longevity or disability in a sample of Italian octo- and nonagenarians. Bader G; Zuliani G; Kostner GM; Fellin R Gerontology; 1998; 44(5):293-9. PubMed ID: 9693262 [TBL] [Abstract][Full Text] [Related]
3. Low density lipoprotein cholesterol, lipoprotein(a), and apo(a) isoforms in the elderly: relationship to fasting insulin. Associazione Medica Sabin. Carantoni M; Zuliani G; Bader G; Palmieri E; Volpato S; Passaro A; Imbastaro T; Mezzetti A; Fellin R Nutr Metab Cardiovasc Dis; 1999 Oct; 9(5):228-33. PubMed ID: 10656169 [TBL] [Abstract][Full Text] [Related]
5. Circulating thyroid autoantibodies in a sample of Italian octo-nonagenarians: relationship to age, sex, disability, and lipid profile. Mariotti S; Barbesino G; Chiovato L; Marinò M; Pinchera A; Zuliani G; Mezzetti A; Fellin R Aging (Milano); 1999 Dec; 11(6):362-6. PubMed ID: 10738850 [TBL] [Abstract][Full Text] [Related]
6. Paraoxonase polymorphisms PON1 192 and 55 and longevity in Italian centenarians and Irish nonagenarians. A pooled analysis. Rea IM; McKeown PP; McMaster D; Young IS; Patterson C; Savage MJ; Belton C; Marchegiani F; Olivieri F; Bonafe M; Franceschi C Exp Gerontol; 2004 Apr; 39(4):629-35. PubMed ID: 15050299 [TBL] [Abstract][Full Text] [Related]
7. Lipoprotein(a) levels and apolipoprotein(a) isoforms related to life style risk factors. Ishikawa S; Deguchi T; Hara K; Takuma S; Kayaba K; Tsutsumi A; Kario K; Igarashi M J Epidemiol; 1999 Feb; 9(1):32-9. PubMed ID: 10098351 [TBL] [Abstract][Full Text] [Related]
8. Elevated lipoprotein(a) levels and small apo(a) isoforms are compatible with longevity: evidence from a large population of French centenarians. Thillet J; Doucet C; Chapman J; Herbeth B; Cohen D; Faure-Delanef L Atherosclerosis; 1998 Feb; 136(2):389-94. PubMed ID: 9543111 [TBL] [Abstract][Full Text] [Related]
9. Lipoprotein (a) levels and apolipoprotein (a) isoform size in patients with subclinical hypothyroidism: effect of treatment with levothyroxine. Milionis HJ; Efstathiadou Z; Tselepis AD; Bairaktari ET; Tsironis LD; Tsatsoulis A; Elisaf MS Thyroid; 2003 Apr; 13(4):365-9. PubMed ID: 12804105 [TBL] [Abstract][Full Text] [Related]
10. Associations among serum lipoprotein(a) levels, apolipoprotein(a) phenotypes, and myocardial infarction in patients with extremely low and high levels of serum lipoprotein(a). Saku K; Zhang B; Liu R; Shirai K; Arakawa K Jpn Circ J; 1999 Sep; 63(9):659-65. PubMed ID: 10496479 [TBL] [Abstract][Full Text] [Related]
11. Decreased plasma levels of lipoprotein(a) in patients with hypertriglyceridemia. Bartens W; Rader DJ; Talley G; Brewer HB Atherosclerosis; 1994 Aug; 108(2):149-7. PubMed ID: 7980714 [TBL] [Abstract][Full Text] [Related]
12. Determination of Lp(a) and APO(a) in an Italian population. Cuchel M; Merati G; Clerici M; Grumelli B; Giudici GA; Vergani C Ric Clin Lab; 1991; 21(1):127-34. PubMed ID: 1830970 [TBL] [Abstract][Full Text] [Related]
13. In search of a biological pattern for human longevity: impact of apo A-IV genetic polymorphisms on lipoproteins and the hyper-Lp(a) in centenarians. Pepe G; Di Perna V; Resta F; Lovecchio M; Chimienti G; Colacicco AM; Capurso A Atherosclerosis; 1998 Apr; 137(2):407-17. PubMed ID: 9622284 [TBL] [Abstract][Full Text] [Related]
14. Lipoprotein(a) concentrations, apolipoprotein(a) isoforms and clinical endpoints in haemodialysis patients with type 2 diabetes mellitus: results from the 4D Study. Kollerits B; Drechsler C; Krane V; Lamina C; März W; Dieplinger H; Ritz E; Wanner C; Kronenberg F; Nephrol Dial Transplant; 2016 Nov; 31(11):1901-1908. PubMed ID: 26754832 [TBL] [Abstract][Full Text] [Related]
15. A prospective case-control study of lipoprotein(a) levels and apo(a) size and risk of coronary heart disease in Stanford Five-City Project participants. Wild SH; Fortmann SP; Marcovina SM Arterioscler Thromb Vasc Biol; 1997 Feb; 17(2):239-45. PubMed ID: 9081676 [TBL] [Abstract][Full Text] [Related]
17. High lipoprotein(a) levels with predominance of high molecular weight apo(a) isoforms in patients with pulmonary embolism. Császár A; Karádi I; Juhász E; Romics L Eur J Clin Invest; 1995 May; 25(5):368-70. PubMed ID: 7628525 [TBL] [Abstract][Full Text] [Related]
18. Serum distribution of lipoprotein(a) in African Americans and Nigerians: potential evidence for a genotype-environmental effect. Rotimi CN; Cooper RS; Marcovina SM; McGee D; Owoaje E; Ladipo M Genet Epidemiol; 1997; 14(2):157-68. PubMed ID: 9129961 [TBL] [Abstract][Full Text] [Related]
19. Role of lipoprotein(a) and apolipoprotein(a) phenotype in atherogenesis: prospective results from the Bruneck study. Kronenberg F; Kronenberg MF; Kiechl S; Trenkwalder E; Santer P; Oberhollenzer F; Egger G; Utermann G; Willeit J Circulation; 1999 Sep; 100(11):1154-60. PubMed ID: 10484534 [TBL] [Abstract][Full Text] [Related]
20. Lp(a) concentration and apo(a) isoform size. Relation to the presence of coronary artery disease in familial hypercholesterolemia. Bowden JF; Pritchard PH; Hill JS; Frohlich JJ Arterioscler Thromb; 1994 Oct; 14(10):1561-8. PubMed ID: 7918305 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]